AU Patent

AU2010253776B2 — Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems

Assigned to Pearl Therapeutics Inc · Expires 2015-01-22 · 11y expired

What this patent protects

Compositions, methods and systems are provided for pulmonary delivery of long-acting muscarinic antagonists and long-acting β

USPTO Abstract

Compositions, methods and systems are provided for pulmonary delivery of long-acting muscarinic antagonists and long-acting β

Drugs covered by this patent

Patent Metadata

Patent number: AU2010253776B2
Jurisdiction: AU
Classification: —
Expires: 2015-01-22
Drug substance claim: No
Drug product claim: No
Assignee: Pearl Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.